Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on January 07,2023, regarding the loss /misplacement of the share certificate(s) Procter & Gamble Health Ltd - 500126 - Board Meeting Intimation for Unaudited Financial Results And The Declaration Of Interim Dividend, If Any.
Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, February 8, 2023, inter alia, to consider and approve the unaudited financial results for the quarter ended December 31,2022 and the declaration of interim dividend for the Financial Year 2022-23, if any. Kindly take the same on record.
Covid-19 strategy was 'optimised', says Chinese premier Xi Jinping
Country approves Merck's Covid-19 antiviral as drug shortage continues Procter & Gamble Health Ltd - 500126 - Closure of Trading Window
We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from January 1, 2023 until 48 hours from the publication of the unaudited financial results for quarter ended December 31, 2022.
Wall St rises after CPI data but Fed concerns persist; Moderna, Merck shares up
The benchmark S&P 500 jumped as much as 2.76% to a three-month high early in the trading session on news that November.
Innovator drugs maintain market hold even after patent expiry, shows data
Merck's anti-diabetic molecule sitagliptin retains 81% market share in value terms Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015,we hereby inform you regarding issue of duplicate share certificate(s) to the shareholder(s) of the Company, on November 29,2022. Procter & Gamble Health Ltd - 500126 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We have been informed by our Registrars and Share Transfer Agents (RTA), KFin Technologies Limited on November 28,2022, regarding the loss /misplacement of the share certificate(s). We request you to take the same on record and acknowledge receipt. Procter & Gamble Health Ltd - 500126 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
We are pleased to informed that the Shareholders of the Company have at their Annual General Meeting held on November 23, 2022, approved re-appointment of M/s. Haribhakti & Co. LLP, Chartered Accountants, as the Statutory Auditors for a second term of 5 (five) years ie. to hold office from the conclusion of this 55th Annual General Meeting upto the conclusion of 60th Annual General Meeting of the Company. Procter & Gamble Health Ltd - 500126 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We would like to inform you that the 55th Annual General Meeting of the Company was held on November 23, 2022 at 3.30 p.m. through Video Conference / Other Audio-Visual Means. In this respect, please find enclosed below: 1. Voting results in respect of the business conducted at the Annual General Meeting, as required under Regulation 44 (3) of the SEBI (Listing Obligations & Disclosure Requirements), Regulations, 2015; and 2. Scrutinizer's Report Kindly take the above on record and oblige.